Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Merck
Moodys
Chinese Patent Office
Daiichi Sankyo
Argus Health
US Department of Justice
UBS
Accenture
Healthtrust

Generated: February 23, 2018

DrugPatentWatch Database Preview

EPIRUBICIN HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Epirubicin Hydrochloride patents expire, and when can generic versions of Epirubicin Hydrochloride launch?

Epirubicin Hydrochloride is a drug marketed by Actavis Totowa, Akorn Inc, Cipla Ltd, Ebewe Pharma, Fresenius Kabi Oncol, Fresenius Kabi Usa, Hisun Pharm Hangzhou, Hospira, Impax Labs Inc, Mustafa Nevsat, Mylan Institutional, Mylan Labs Ltd, and West-ward Pharms Int. and is included in fourteen NDAs.

The generic ingredient in EPIRUBICIN HYDROCHLORIDE is epirubicin hydrochloride. There are nine drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the epirubicin hydrochloride profile page.
Drug patent expirations by year for EPIRUBICIN HYDROCHLORIDE
Pharmacology for EPIRUBICIN HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for EPIRUBICIN HYDROCHLORIDE

US Patents and Regulatory Information for EPIRUBICIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira EPIRUBICIN HYDROCHLORIDE epirubicin hydrochloride INJECTABLE;IV (INFUSION) 050807-002 Sep 15, 2006 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Labs Ltd EPIRUBICIN HYDROCHLORIDE epirubicin hydrochloride INJECTABLE;INJECTION 091599-002 Mar 12, 2012 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int EPIRUBICIN HYDROCHLORIDE epirubicin hydrochloride INJECTABLE;INJECTION 065289-001 Jun 27, 2007 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Actavis Totowa EPIRUBICIN HYDROCHLORIDE epirubicin hydrochloride INJECTABLE;INJECTION 065445-001 Sep 18, 2008 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira EPIRUBICIN HYDROCHLORIDE epirubicin hydrochloride INJECTABLE;INJECTION 065343-002 Apr 19, 2007 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mustafa Nevsat EPIRUBICIN HYDROCHLORIDE epirubicin hydrochloride INJECTABLE;INJECTION 090266-002 Apr 15, 2011 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ebewe Pharma EPIRUBICIN HYDROCHLORIDE epirubicin hydrochloride INJECTABLE;INJECTION 065339-001 Dec 22, 2009 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Akorn Inc EPIRUBICIN HYDROCHLORIDE epirubicin hydrochloride INJECTABLE;INJECTION 090163-001 Jun 24, 2009 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fresenius Kabi Usa EPIRUBICIN HYDROCHLORIDE epirubicin hydrochloride INJECTABLE;INJECTION 065408-002 Oct 15, 2007 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira EPIRUBICIN HYDROCHLORIDE epirubicin hydrochloride INJECTABLE;INJECTION 065343-004 Apr 19, 2007 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
McKinsey
AstraZeneca
Argus Health
Colorcon
Harvard Business School
Cantor Fitzgerald
Farmers Insurance
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot